Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Halamoda-Kenzaoui, BlankaBaconnier, Simon
Bastogne, Thierry
Bazile, Didier
Boisseau, Patrick
Borchard, Gerrit
Borgos, Sven Even
Calzolai, Luigi
Cederbrant, Karin
Di Felice, Gabriella
Di Francesco, Tiziana
Dobrovolskaia, Marina A
Gaspar, Rogério
Gracia, Belén
Hackley, Vincent A
Leyens, Lada
Liptrott, Neill
Park, Margriet
Patri, Anil
Roebben, Gert
Roesslein, Matthias
Thürmer, René
Urbán, Patricia
Zuang, Valérie
Bremer-Hoffmann, Susanne
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Bridging communities in the field of nanomedicine.Published in
Regul Toxicol Pharmacol 2019; 106:187-96PMID
31051191ae974a485f413a2113503eed53cd6c53
10.1016/j.yrtph.2019.04.011
Scopus Count
Collections
Related articles
- Mapping of the available standards against the regulatory needs for nanomedicines.
- Authors: Halamoda-Kenzaoui B, Holzwarth U, Roebben G, Bogni A, Bremer-Hoffmann S
- Issue date: 2019 Jan
- Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures.
- Authors: He H, Liu L, Morin EE, Liu M, Schwendeman A
- Issue date: 2019 Sep 17
- Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?
- Authors: Mühlebach S
- Issue date: 2018 Jun
- Regulatory aspects on nanomedicines.
- Authors: Sainz V, Conniot J, Matos AI, Peres C, Zupancic E, Moura L, Silva LC, Florindo HF, Gaspar RS
- Issue date: 2015 Dec 18
- Nanomedicines in the EU-Regulatory Overview.
- Authors: Pita R, Ehmann F, Papaluca M
- Issue date: 2016 Nov